PATENT CLAIM ANALYSIS

Application Number: 15905158
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "021700"]

Abstract:
The present invention provides polypeptide modulators of complement activity, including cyclic polypeptide modulators. Also provided are methods of utilizing such modulators as therapeutics.

Claim (Index 15):
The method of  claim 14 , wherein the C5 inhibitor is administered at a dose sufficient to achieve C5 inhibitor plasma levels in the subject of about 4 \u03bcg/ml.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 88.0
- Lexical Diversity: 1.2381
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15547085', '15318063', '14573423', '13783633', '16065272']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7552497474788183
- 35 USC 102 Novelty (BERT): 0.5850516833515504
- Combined Prediction Score: 0.7382299410660916
- Mean Citation Score: 365.156436
- Max Citation Score: 618.9555
- Similarity Product: 364.3492914268077

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test